Authored By: Sarah
11 Jul 2024

 Oral Cancer Therapeutics Market Size to grow by USD 1615.4 million between 2024-2028

According to a research report “ Oral Cancer Therapeutics Market” by Product (Targeted therapy, Chemotherapy) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 1615.4 million, at a CAGR of  10.03% during the forecast period. The global oral cancer therapeutics market is experiencing significant growth due to the rising prevalence and incidence of oral cancer, with approximately 54,000 Americans expected to be diagnosed with oral cavity and pharynx cancer in the US this year. Despite advancements in chemotherapy and targeted therapy, the high mortality rate is attributed to late-stage diagnoses. This unmet need for early detection and effective treatments presents a substantial opportunity for pharmaceutical companies to introduce innovative therapeutic solutions, thereby fueling market expansion. Ongoing research and development efforts in diagnostic modalities aim to improve early detection rates, further boosting market potential.

Browse market data tables, figures, and in-depth TOC on “Oral Cancer Therapeutics Market” by Product (Targeted therapy, Chemotherapy) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Product, the Targeted therapy segment is projected to dominate the market size in 2024

ai_market_segmentation_by

By Geography, North America  segment is expected to hold the largest market size for the year 2024

The oral cancer therapeutics market represents a significant business opportunity due to the rising prevalence of oral cancer and the increasing demand for effective treatments. Key players in this market are focusing on developing innovative therapies, including targeted therapies and immunotherapies, to address the unmet medical needs of patients. Additionally, the market is expected to grow due to the increasing geriatric population, which is more susceptible to oral cancer. Overall, the oral cancer therapeutics market is a dynamic and growing business sector, driven by advancements in technology and a growing focus on improving patient outcomes.

North America is forecasted to hold the largest market size by region in 2024

The oral cancer therapeutics market represents a significant business opportunity due to the rising prevalence of oral cancer worldwide. Key players in this market are focusing on developing innovative treatments to address the unmet medical needs of patients. Advanced technologies, such as targeted therapies and immunotherapies, are gaining traction in the market. The market is expected to grow at a robust rate, driven by increasing awareness, improving healthcare infrastructure, and rising disposable income in emerging economies.

The Oral Cancer Therapeutics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Amneal Pharmaceuticals Inc.
  • AstraZeneca Plc
  • Bristol Myers Squibb Co.
  • Cipla Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Viatris Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Title: Oral Cancer Therapeutics Market: Overcoming Challenges and Advancements The Oral Cancer Therapeutics Market is witnessing significant growth due to the rising prevalence of oral cancer in the elderly population, driven by changing lifestyles, human papillomavirus (HPV) infections, alcohol consumption, and tobacco use. Symptoms such as loss of appetite and mouth sores are common indicators of oral cancer, leading to a need for effective therapeutics. However, oral cancer treatments, including surgery, chemotherapy, and radiation therapy, come with side effects like hair loss and root caries. The Oral Cancer Foundation and healthcare organizations are collaborating with research institutions to develop molecular diagnostics, biomarker testing, imaging technologies, and diagnostic techniques for early detection and minimally invasive surgeries. Dental technology developments, such as advanced imaging systems and targeted therapies, are also transforming the oral cancer treatment landscape. The Geriatric Population, with its unique needs and challenges, is a key focus area for these advancements. The market for oral cancer therapeutics is expected to continue growing, offering opportunities for innovation and improved patient outcomes.

Market Research Overview

The Oral Cancer Therapeutics Market is witnessing significant growth due to the increasing number of cases worldwide. ENT specialists, dentists, hospitals, and clinics are at the forefront of diagnosing and treating oral cancer, with conditions such as erythroplakia and oral leukoplakia being common precursors. Risk factors like Type 2 diabetes, human papillomavirus infection, smoking, and alcohol consumption contribute to the disease's prevalence. Clinical trials are underway for advanced technologies like molecular diagnostics, biomarker testing, and imaging technologies to improve early detection. Conditions like verrucous carcinoma and squamous cell carcinoma require specialized treatment, often involving surgery, chemotherapy, and radiation therapy. Dentures and lack of dexterity in the elderly population can make oral examinations challenging. Imaging tests and biopsies are essential for accurate diagnosis, but they can come with side effects like nausea, vomiting, loss of appetite, mouth sores, and hair loss. The global footprint of oral cancer is expanding due to the growing geriatric population and changing lifestyles. Dental technology developments, such as remote monitoring and telemedicine, and patient-centric approaches by healthcare organizations and research institutions, are transforming oral cancer treatment. Oral Cancer Foundation initiatives aim to increase awareness and access to care. Targeted therapy and minimally invasive surgeries are also emerging as effective oral cancer treatments.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio